Takeda Pharmaceutical Co Ltd - Company Profile

Powered by

All the data and insights you need on Takeda Pharmaceutical Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Takeda Pharmaceutical Co Ltd Strategy Report

  • Understand Takeda Pharmaceutical Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Takeda Pharmaceutical Co Ltd: Executives

The following section provides information on Takeda Pharmaceutical Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Takeda Pharmaceutical Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Christophe Weber

Chief Executive Officer; Director; President Executive Board Since: 2015 Age: 57

Mr. Christophe Weber has been the Director, President and Chief Executive Officer of the company since 2015. Prior to this, he served as Chief Operating Officer, President and Representative Director of the company in 2014. Mr. Weber also held various senior leadership roles in GlaxoSmithKline in Europe, Asia and the US.

Read Hide full bio of Christophe Weber

Milano Furuta

Chief Financial Officer Senior Management Since: 2024

Mr. Milano Furuta has been the Chief Financial Officer of the company since April 1, 2024. Previously, he was the President of Takeda’s Japan Pharma Business Unit from April 2021 to March 2024. From January 2019 to March 2021 Mr. Furuta worked as Corporate Strategy Officer and Chief Of Staff at Takeda. Prior to this, he served as an Equity Research Analyst at an investment management firm in the US.

Read Hide full bio of Milano Furuta

Gabriele Ricci

Chief Data and Technology Officer Senior Management Since: 2022 Age: 45

Mr. Gabriele Ricci has been the Chief Data and Technology Officer of the company since February 2022.Previously, he served as Head of IT for the Plasma-Derived Therapies Business Unit.

Read Hide full bio of Gabriele Ricci

Takako Ohyabu

Chief Global Corporate Affairs Officer Senior Management Since: 2019 Age: 44

Ms. Takako Ohyabu has been the Chief Global Corporate Affairs Officer of the company since 2019. Prior to this, she served as the Chief Communications and Public Affairs Officer Designate of the company. Ms. Ohyabu served the Global Corporate Communications function at Nissan Motor Corporation.

Read Hide full bio of Takako Ohyabu

Mwana Lugogo

Chief Ethics & Compliance Officer Senior Management Since: 2019 Age: 53

Ms. Mwana Lugogo has been the Chief Ethics and Compliance Officer of the company since 2019. She joined the company to establish the Compliance function for Growth & Emerging Market Business Unit, and lead the newly-created Global Ethics & Compliance organization in 2015.

Read Hide full bio of Mwana Lugogo
Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward